Alpha Tau Medical Ltd(DRTS)

Biotechnology · Jerusalem, JM

$14.48-0.41 (-2.75%)

Delayed quote: Oct 6, 2026, 11:10 AM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T15:11:49.775Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:11:49.775Z.

Quote observation: 2026-10-06T15:10:25.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,307,918,684
TTM operating cash flow · period ending 2025-12-31: N/A

FMP input reference: d0cade57d6bc8828dc71ac364ddc44a4328d7c948fb2699a56d4eea8e3f6e5b7

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

DRTS Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

DRTS Competitors' Price/OCF Ratio

DRTS

Alpha Tau Medical Ltd

Current

Market Cap

$1.31B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COAG

Hemab Therapeutics Holdings, Inc. Common Stock

vs DRTS

Market Cap

$1.35B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OMER

Omeros Corporation

vs DRTS

Market Cap

$1.36B

Price/OCF Ratio

N/A

TTM Avg

2.58

3Y Avg

2.59

5Y Avg

2.59

KARD

Kardigan, Inc.

vs DRTS

Market Cap

$1.25B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORIC

ORIC Pharmaceuticals, Inc.

vs DRTS

Market Cap

$1.24B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRON

Cronos Group Inc.

vs DRTS

Market Cap

$1.22B

Price/OCF Ratio

20.24

TTM Avg

36.33

3Y Avg

71.26

5Y Avg

71.26

INBX

Inhibrx Biosciences Inc.

vs DRTS

Market Cap

$1.41B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OMDA

Omada Health

vs DRTS

Market Cap

$1.22B

Price/OCF Ratio

51.35

TTM Avg

51.28

3Y Avg

51.28

5Y Avg

51.28

INNV

Innovage Holding Corp.

vs DRTS

Market Cap

$1.21B

Price/OCF Ratio

18.75

TTM Avg

22.01

3Y Avg

32.46

5Y Avg

37.26

KLRA

Kailera Therapeutics, Inc.

vs DRTS

Market Cap

$1.42B

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Alpha Tau Medical Ltd (DRTS)	$1.31B	N/A	N/A	N/A	N/A
Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs ›	$1.35B	N/A	N/A	N/A	N/A
Omeros Corporation (OMER)vs ›	$1.36B	N/A	2.58	2.59	2.59
Kardigan, Inc. (KARD)vs ›	$1.25B	N/A	N/A	N/A	N/A
ORIC Pharmaceuticals, Inc. (ORIC)vs ›	$1.24B	N/A	N/A	N/A	N/A
Cronos Group Inc. (CRON)vs ›	$1.22B	20.24	36.33	71.26	71.26
Inhibrx Biosciences Inc. (INBX)vs ›	$1.41B	N/A	N/A	N/A	N/A
Omada Health (OMDA)vs ›	$1.22B	51.35	51.28	51.28	51.28
Innovage Holding Corp. (INNV)vs ›	$1.21B	18.75	22.01	32.46	37.26
Kailera Therapeutics, Inc. (KLRA)vs ›	$1.42B	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

DRTS Price/OCF Ratio Metrics

DRTS Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics